Pharmaxis Ltd

Press Releases

2015-December-16	Bronchitol Paediatric Cystic Fibrosis Clinical Trial Reports Positive Results (in PDF)
2015-November-19	Annual General Meeting 19 November 2015 Sydney Chairman's Address by Malcolm J McComas (in PDF)
2015-September-22	Pharmaxis Releases Successful Results of Phase 1 Clinical Trial for Boehringer Ingelheim Partnered Drug PXS-4728A (in PDF)
2015-August-5	Pharmaxis and Synairgen Announce Research Collaboration to Develop Loxl2 Inhibitor for Pulmonary Fibrosis (in PDF)
2015-May-19	Pharmaxis Announces Completion of Restructuring and New Focus on Partnering (in PDF)
2015-May-18	Boehringer Ingelheim Acquires Pharmaxis' Phase 1 Anti-inflammatory Drug Candidate (in PDF)
2015-May-8	Pharmaxis Signs Second Agreement with Chiesi (in PDF)
2015-April-17	Shareholder Update - March Quarter 2015 (in PDF)
2015-April-7	Pharmaxis Releases Interim Results of Phase 1 Clinical Trial for SSAO / VAP-1 Inhibitor PXS4728A (in PDF)
2015-March-12	Pharmaxis Signs Agreement with Boehringer Ingelheim for SSAO Inhibitor PXS4728A (in PDF)
2015-January-21	Pharmaxis Announces Commencement of Phase 1 Clinical Trial for Novel SSAO / VAP-1 Inhibitor (in PDF)
2017	2017 Press Releases
2016	2016 Press Releases
2014	2014 Press Releases
2013	2013 Press Releases
2012	2012 Press Releases
2011	2011 Press Releases
2010	2010 Press Releases
2009	2009 Press Releases
2008	2008 Press Releases
2007	2007 Press Releases
2006	2006 Press Releases
2005	2005 Press Releases
2004	2004 Press Releases